Compile Data Set for Download or QSAR
maximum 50k data
Found 91 with Last Name = 'takenouchi' and Initial = 'o'
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395262(CHEMBL2163999)
Affinity DataKi:  6.00E+3nMAssay Description:Competitive inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP by Lineweaver-Burke plot analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395284(CHEMBL2163996)
Affinity DataIC50:  3nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395283(CHEMBL2163995)
Affinity DataIC50:  3.40nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395285(CHEMBL2163997)
Affinity DataIC50:  4nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395272(CHEMBL1231206)
Affinity DataIC50:  5nMAssay Description:Binding affinity to recombinant MAPKAP-K2 using KKKALSRQLSVAA as substrate after 4 mins by surface plasmon resonance spectroscopic analysisMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395267(CHEMBL2163608)
Affinity DataIC50:  54nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395262(CHEMBL2163999)
Affinity DataIC50:  55nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395269(CHEMBL2163610)
Affinity DataIC50:  57nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395268(CHEMBL2163611)
Affinity DataIC50:  76nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395275(CHEMBL2163616)
Affinity DataIC50:  130nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395274(CHEMBL1235213)
Affinity DataIC50:  130nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50225787(2,4-diamino-6,7-dihydroxy-10H-9-oxa-1-aza-anthrace...)
Affinity DataIC50:  130nMAssay Description:Inhibition of MAPKAP-K2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395270(CHEMBL2163609)
Affinity DataIC50:  140nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395271(CHEMBL2163612)
Affinity DataIC50:  160nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395266(CHEMBL2163607)
Affinity DataIC50:  200nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395303(CHEMBL2163981)
Affinity DataIC50:  360nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395266(CHEMBL2163607)
Affinity DataIC50:  390nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395282(CHEMBL2163994)
Affinity DataIC50:  400nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50059889((staurosporine)3-methoxy-2-methyl-4-methylamino-(2...)
Affinity DataIC50:  400nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395281(CHEMBL2163993)
Affinity DataIC50:  400nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395278(CHEMBL2163984)
Affinity DataIC50:  400nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395263(CHEMBL2163604)
Affinity DataIC50:  400nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395277(CHEMBL2163624)
Affinity DataIC50:  510nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395295(CHEMBL2163625)
Affinity DataIC50:  570nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395280(CHEMBL2163992)
Affinity DataIC50:  600nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395278(CHEMBL2163984)
Affinity DataIC50:  700nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395276(CHEMBL2163623)
Affinity DataIC50:  700nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395290(CHEMBL2163618)
Affinity DataIC50:  700nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395289(CHEMBL2163617)
Affinity DataIC50:  700nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395263(CHEMBL2163604)
Affinity DataIC50:  1.20E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395262(CHEMBL2163999)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395288(CHEMBL2163613)
Affinity DataIC50:  1.40E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395264(CHEMBL2163605)
Affinity DataIC50:  1.50E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395279(CHEMBL2163991)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395265(CHEMBL2163606)
Affinity DataIC50:  1.70E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase Chk2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395274(CHEMBL1235213)
Affinity DataIC50:  1.70E+3nMAssay Description:Inhibition of human CHK2 by radiometric assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395287(CHEMBL2163614)
Affinity DataIC50:  1.90E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395310(CHEMBL2163989)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395280(CHEMBL2163992)
Affinity DataIC50:  2.10E+3nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395301(CHEMBL2163979)
Affinity DataIC50:  2.50E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395286(CHEMBL2163615)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395285(CHEMBL2163997)
Affinity DataIC50:  3.10E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395281(CHEMBL2163993)
Affinity DataIC50:  3.60E+3nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395299(CHEMBL2163353)
Affinity DataIC50:  4.10E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395262(CHEMBL2163999)
Affinity DataIC50:  4.90E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Mus musculus)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395274(CHEMBL1235213)
Affinity DataIC50:  5.00E+3nMAssay Description:Inhibition of MAPKAP-K2 in mouse whole blood assessed as inhibition of LPS-induced TNFalpha production by ELISAMore data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395279(CHEMBL2163991)
Affinity DataIC50:  6.00E+3nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395265(CHEMBL2163606)
Affinity DataIC50:  6.40E+3nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395291(CHEMBL2163619)
Affinity DataIC50:  7.00E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50395274(CHEMBL1235213)
Affinity DataIC50:  7.20E+3nMAssay Description:Inhibition of human MAPKAP-K2 in THP1 cells assessed as inhibition of LPS-induced TNFalpha production incubated 1 hr prior to LPS challenge measured ...More data for this Ligand-Target Pair
Displayed 1 to 50 (of 91 total ) | Next | Last >>
Jump to: